X
NICE backs NHS use of Takeda’s Adcetris for rare blood cancer
https://pharmaphorum.com/news/nice-backs-nhs-use-of-takedas-adcetris-for-rare-blood-cancer/
Adcetris
Adcetris falls victim to NICE’s Cancer Drugs Fund clear-out
More CDF legacy products likely to face same fate